• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER DUCT OCCLUDER (UNKNOWN); TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER DUCT OCCLUDER (UNKNOWN); TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Device Problem Off-Label Use (1494)
Patient Problems Atrial Flutter (1730); Tachycardia (2095); Pericardial Effusion (3271); Heart Block (4444)
Event Type  Injury  
Manufacturer Narrative
In an research article, one ventricular tachycardia managed with cardioversion, one atrial flutter managed with cardioversion one transient complete heart block, transient shunts and one mild pericardial effusion with spontaneous resolve were reported.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.Please note, per the pda duct occluder instructions for use, arten600038221- a "indications and usage: the amplatzer¿ duct occluder is a percutaneous, transcatheter occlusion device intended for the nonsurgical closure of a patent ductus arteriosus (pda).".
 
Event Description
Related manufacturing reference number: 2135147-2021-00434.The article, "transcatheter closure of residual and iatrogenic ventricular septal defects: tertiary center experience and outcome" was reviewed.This research article is a retrospective single center experience to assess long term outcome of transcatheter closure of post-surgical and post-intervention residual and iatrogenic ventricular septal defects (vsds).Amplatzer muscular vsd occluder, amplatzer duct occluder and amplatzer duct occluder ii were associated with the study.The article concluded that transcatheter closure of post-operative and post-intervention residual/iatrogenic vsds represents a safe, feasible, and effective therapeutic approach.The primary and correspondence author of the article is fatma a.Taha, adult cardiology department, madinah cardiac center, khaled bin waleed road, madinah 6167, saudi arabia with the corresponding email: fatmastaha@yahoo.Com.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER DUCT OCCLUDER (UNKNOWN)
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key12705035
MDR Text Key278603703
Report Number2135147-2021-00435
Device Sequence Number1
Product Code MAE
Combination Product (y/n)N
Reporter Country CodeSA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 10/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/27/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received09/27/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age14 YR
Patient Weight36
-
-